These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Development of quantitative molecular clinical end points for siRNA clinical trials. Hickerson RP; Leachman SA; Pho LN; Gonzalez-Gonzalez E; Smith FJ; McLean WH; Contag CH; Leake D; Milstone LM; Kaspar RL J Invest Dermatol; 2011 May; 131(5):1029-36. PubMed ID: 21191405 [TBL] [Abstract][Full Text] [Related]
9. Molecular medicine for the brain: silencing of disease genes with RNA interference. Davidson BL; Paulson HL Lancet Neurol; 2004 Mar; 3(3):145-9. PubMed ID: 14980529 [TBL] [Abstract][Full Text] [Related]
10. RNA interference in neuroscience: progress and challenges. Miller VM; Paulson HL; Gonzalez-Alegre P Cell Mol Neurobiol; 2005 Dec; 25(8):1195-207. PubMed ID: 16388332 [TBL] [Abstract][Full Text] [Related]
11. A novel measurement of allele discrimination for assessment of allele-specific silencing by RNA interference. Takahashi M; Hohjoh H Mol Biol Rep; 2014 Nov; 41(11):7115-20. PubMed ID: 25037272 [TBL] [Abstract][Full Text] [Related]
12. Allele-specific silencing of dominant disease genes. Miller VM; Xia H; Marrs GL; Gouvion CM; Lee G; Davidson BL; Paulson HL Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7195-200. PubMed ID: 12782788 [TBL] [Abstract][Full Text] [Related]
13. SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita. Hickerson RP; Smith FJ; McLean WH; Landthaler M; Leube RE; Kaspar RL Ann N Y Acad Sci; 2006 Oct; 1082():56-61. PubMed ID: 17145926 [TBL] [Abstract][Full Text] [Related]
14. Small RNA: can RNA interference be exploited for therapy? Wall NR; Shi Y Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643 [TBL] [Abstract][Full Text] [Related]